The antiviral drugs champ is paying $12 billion for a promising cancer therapy to jump-start growth. Read More
Igor Greenwald is chief investment strategist of Breakthrough Technology Profits and Income Millionaire.
Igor served as a financial columnist and has also worked as a newspaper editor, foreign correspondent and online producer. He was born in Ukraine, educated at Georgetown University and lives in Massachusetts.
Analyst Articles
The latest portfolio addition delivered blowout earnings this week. But we could get another chance to buy it cheaper. Read More
One’s a growth engine with a yield set to more than double within three years, and the other is already delivering high income. Read More
Economic recovery remains on track despite the presidential corruption scandal, and the stock market has room to run. Read More
Our favorite suffered a mild letdown last week on great earnings news. It’s time to buy again. Read More
Economic recovery remains on track despite the presidential corruption scandal, and the stock market has room to run. Read More
An update on one of the portfolio’s problem stocks ahead of a crucial quarterly update. Read More
The machine-vision champ delivered another quarter of blowout results and the stock responded. It’s not too late to buy. Read More
The portfolio’s problem stock is downgraded to Hold ahead of a crucial quarterly update. Read More
Funds offering hefty payouts from diversified income portfolios are a dime a dozen, but most have a history of subpar returns. Read More